Deprenyl, a therapeutic agent for Parkinson's disease, inhibits arsenic toxicity potentiated by GSH depletion via inhibition of JNK activation
김상건
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2004
163
Arctigenin, a phenylpropanoid dibenzylbutyrolactone lignan, inhibits MAP kinases and AP-1 activation via potent MKK inhibition: the role in TNF-alpha inhibition
김상건
INTERNATIONAL IMMUNOPHARMACOLOGY, 2004
164
Hyaluronic acid inhibits adhesion of hepatic stellate cells in spite of its stimulation of DNA synthesis
김상건
TISSUE & CELL, 2004
165
Ceramide, an apoptotic rheostat, inhibits CCAAT/enhancer binding protein-beta and NF-E2-related factor-2 activation: The role in glutathione S-transferase A2 gene repression
김상건
DRUG METABOLISM AND DISPOSITION, 2004
166
Effects of acute renal failure on the pharmacokinetics of oltipraz in rats
김상건
JOURNAL OF PHARMACEUTICAL SCIENCES, 2004
167
Effects of cysteine on the pharmacokinetics of intravenous torasemide in rats with protein-calorie malnutrition
김상건
JOURNAL OF PHARMACEUTICAL SCIENCES, 2004
168
Pharmacokinetics of clarithromycin in rats with acute renal failure induced by uranyl nitrate
김상건
BIOPHARMACEUTICS & DRUG DISPOSITION, 2004
169
Synthesis and anti-inflammatory effects of novel pimarane diterpenoid analogs
김상건
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004
170
Induction of cyclooxygenase-2 by bovine type I collagen in macrophages via C/EBP and CREB activation by multiple cell signaling pathways